EWING SARCOMA
Clinical trials for EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EWING SARCOMA trials appear
Sign up with your email to follow new studies for EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could your own tumor cells beat cancer? new trial for kids and young adults
Disease control OngoingThis early-stage study tests a treatment made from a patient's own tumor-fighting immune cells (TIL). It is for children, teenagers, and young adults (ages up to 21) with certain solid cancers that have come back or stopped responding to standard treatments. The main goal is to s…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New hope for kids with rare cancers: targeted drug shows promise
Disease control OngoingThis study tests an oral drug called cabozantinib in children and young adults (up to age 30) with sarcomas, Wilms tumor, or other rare cancers that have come back or not responded to treatment. The drug works by blocking certain enzymes that help tumors grow and form blood vesse…
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New hope for kids with tough cancers: experimental drug CLR 131 tested
Disease control OngoingThis study tests an experimental drug, CLR 131, in children, adolescents, and young adults with certain cancers (like neuroblastoma, lymphoma, and brain tumors) that have come back or not responded to standard treatments. The main goal is to find a safe dose and see if the drug c…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New flavored chemo drink aims to ease treatment for kids with hard-to-treat cancers
Disease control OngoingThis early-stage study tests a flavored, drinkable version of the chemotherapy drug irinotecan (VAL-413) combined with another drug (temozolomide) in children and young adults up to age 30 whose solid tumors have come back. The main goal is to find the safest and most effective d…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Valent Technologies, LLC • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Promising drug combo targets Hard-to-Treat bone cancer
Disease control OngoingThis early-phase trial tests whether adding the targeted drug regorafenib to standard chemotherapy is safe for people with newly diagnosed, widespread Ewing sarcoma. The study includes 23 patients aged 2 to 49 whose cancer has spread beyond the lungs. The main goal is to find the…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Engineered immune cells take aim at childhood cancers in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for children and young adults (up to age 26) with solid tumors that have come back or not responded to standard treatment. The therapy uses the patient's own immune cells, modified to recognize and attack a protein called B…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
Engineered immune cells take on tough childhood cancers in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for children and young adults (ages 1–30) with solid tumors that have returned or not responded to standard treatments. The therapy uses the patient's own immune cells, modified to recognize and attack cancer cells carrying…
Matched conditions: EWING SARCOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:18 UTC
-
New imaging method could help spot tumors in kids with cancer
Diagnosis OngoingThis study tests if a special PET scan using methionine, a natural amino acid, can help see tumors in children and young adults with brain or solid tumors. About 500 participants will get the scan to see how well it finds tumors and tells them apart from scar tissue. The goal is …
Matched conditions: EWING SARCOMA
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Diagnosis
Last updated Jun 09, 2026 12:09 UTC
-
Simple blood test could forecast bone cancer prognosis
Knowledge-focused OngoingThis study looks at whether a simple blood test (liquid biopsy) can help predict how well children and young adults with Ewing sarcoma or osteosarcoma will do. Researchers will check for tumor DNA in the blood at diagnosis and see if it relates to cancer returning. The goal is to…
Matched conditions: EWING SARCOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:29 UTC